Compare Angi Inc (ANGI) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Angi Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Angi Inc trades at $4.5 (market cap $182.30M), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 450.1× Angi Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Angi Inc pays none. Which is the better fit depends on your goals.
| ANGI | REGN | |
|---|---|---|
Market Cap | $182.30M | $82.06B |
Sector | Media | Health |
52-Week High | $18.46 | $812.27 |
52-Week Low | $4.49 | $555.51 |
Enterprise Value | $392.07M | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Angi Inc
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair
Read more on ANGI →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
